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Abstract 
 
Objectives 
 
We aimed to set up a robust multi-centre clinical fMRI and neuropsychological 
platform to investigate the neuropharmacology of brain processes relevant to addiction 
– reward, impulsivity, and emotional reactivity. Here we provide an overview of the 
fMRI battery, carried out across three centres, characterising neuronal response to the 
tasks, along with exploring inter-centre differences in healthy participants. 
 
Experimental Design 
 
Three fMRI tasks were used: monetary incentive delay to probe reward sensitivity; 
go/no-go to probe impulsivity; and an evocative images task to probe emotional 
reactivity. A coordinate-based activation likelihood estimation (ALE) meta-analysis was 
carried out for the reward and impulsivity tasks to help establish region of interest 
(ROI) placement. A group of healthy participants was recruited from across three 
centres (total n=43) to investigate inter-centre differences. 
 
Principle Observations 
 The pattern of response observed for each of the three tasks was consistent with 
previous studies using similar paradigms. At the whole brain level, significant 
differences were not observed between centres for any task. 
 
Conclusions 
 
In developing this platform we successfully integrated neuroimaging data from three 
centres, adapted validated tasks, and applied whole brain and ROI approaches to 
explore and demonstrate their consistency across centres. 
  
Introduction 
 
Addiction is a major global health problem with illicit drug and alcohol use disorders 
contributing to approximately 20% of the burden from mental health disorders 
(Whiteford et al., 2013). Of concern is the lack of effective interventions for these 
disorders whilst the prevalence of alcohol, opioid and cocaine addiction is increasing 
(Lingford-Hughes et al., 2012; Whiteford et al., 2013). The growing knowledge about 
the brain mechanisms underpinning addiction offers an important opportunity to 
develop new treatments. Studying the neurobiology of addiction can be challenging due 
to its common relapsing remitting clinical course. To address this, a collaboration 
between Imperial College London, the University of Cambridge and The University of 
Manchester (ICCAM; http://www.bbmh.manchester.ac.uk/ICCAM/) was formed under 
a Medical Research Council (MRC) addiction initiative to maximise the existing MRI 
and clinical infrastructure and expertise available in the UK. Establishment of a 
platform is necessary to provide sufficient throughput to rapidly evaluate potential 
pharmacological treatments in addiction to allow us the best chance of meeting this area 
of significant unmet need. Here, the term ‘platform’ refers to the concept of applying a 
framework of experimentation (i.e. the fMRI tasks and associated measures) and 
analysis that can be applied under different conditions and on different groups to 
accelerate efforts to identify effective treatments for challenging diseases (Berry et al., 
2015). 
 
The rationale for the cognitive processes and neuropharmacology as well as clinical 
population studied in the ICCAM platform have been described in detail elsewhere 
(Paterson et al., 2015). Its aim was to develop a neuroimaging platform to assess 
candidate brain pathways underpinning addiction and relapse using appropriate fMRI 
tasks and assessing their modulation by different pharmacological challenges 
(antagonists of Dopamine Receptor D3 (DRD3), µ-opioid receptors, and Neurokinin 1 
(NK1) receptors). We were also interested in exploring whether any dysregulation was 
specific to addiction per se or to a particular substance. Therefore we recruited alcohol, 
heroin, and cocaine addicts to compare with healthy non-addicted controls. Results from 
these investigations will be reported elsewhere – this paper focuses on describing the 
establishment of fMRI tasks in the three centres in healthy volunteers and investigating 
their properties, however, we briefly describe our choice of cognitive processes and 
tasks. 
 
fMRI tasks 
 
In addiction, common themes implicated in relapse involve difficulties with reward or 
motivation, impulse control, as well as stress-related emotional reactivity. There is a 
considerable body of evidence from neuroimaging studies that a dysregulated 
reward/motivation system in addiction as well deficits in inhibitory control and poor 
decision making (Loree et al., 2014; Noel et al., 2013), and stress (Koob and Kreek, 
2007; Sinha and Li, 2007) contribute to relapse. We therefore selected established fMRI 
tasks designed to elucidate the neural responses associated with these processes – 
reward/motivation, impulse control and emotional reactivity. 
 
For reward, we chose the widely used monetary incentive delay task since it provides a 
measure of reward sensitivity with robust increases in striatal activity evident in healthy 
volunteers (Knutson et al., 2001). Striatal activity has been shown to be reduced in 
alcohol dependence (Wrase et al., 2007), and in stimulant use related to treatment status 
(Bustamante et al., 2014; Jia et al., 2011; Schouw et al., 2013). Furthermore, ventral 
striatal activation in response to the task is sensitive to pharmacological modulation by 
amphetamines (Knutson et al., 2004), olanzapine (Schlagenhauf et al., 2008), and 
catecholamine depletion (Hasler et al., 2009). 
 
For impulsivity, we chose the go/no-go task since it provides a measure of inhibitory 
control mediated by prefrontal-striatal circuits (Garavan et al., 2002; Garavan et al., 
2003: 2003). Neural responses during go/no-go have been shown to be altered in 
cocaine users (Connolly et al., 2012; Kaufman et al., 2003), opiate addiction (Forman et 
al., 2004), and to be modulated by certain dopaminergic gene variants in heavy drinkers 
(Filbey et al., 2012). 
 
To explore stress we exploited the associated emotional dysregulation since amygdalar 
response is robustly observed and altered in a range of neuroimaging studies of addicts 
(Li and Sinha, 2008; Asensio et al., 2010; Gilman and Hommer, 2008). Therefore, in 
common with others, we used an evocative images task to assess emotional reactivity to 
contrasting aversive images with neutral images from the International Affective Picture 
System (IAPS) library. Photographs containing scenes of animate and inanimate objects 
or scenes were displayed in a block-design, with each block containing either neutral or 
distressing images of an injurious or threatening nature. In addition due to studying 
addiction to different substances and therefore potentially variable cue-reactivity, 
images had no explicit alcohol/drug content. Similar tasks have been shown to elicit 
amygdala responses and have been employed to demonstrate enhanced responses in 
alcohol dependence (Gilman and Hommer, 2008: 2008) that were decreased by an NK1 
receptor antagonist (George et al., 2008). 
 
Meta-Analyses 
 Regions of interest (ROIs) are often used to examine response at one location or small 
region in the brain, as opposed, or in addition to, a more exploratory whole brain 
analysis. These are often chosen based on an investigator’s knowledge of where a task 
has been found to modulate activity in previous work. A more formal way of 
establishing an appropriate a priori ROI is to carry out a coordinate-based meta-analysis 
of neuroimaging data using activation likelihood estimation (ALE) (Turkeltaub et al., 
2002), and its later developments (Eickhoff et al., 2009; Turkeltaub et al., 2012; 
Eickhoff et al., 2012). 
 
Several studies have used these methods to establish locations of consistent response to 
reward (Bartra et al., 2013; Keuken et al., 2014), impulsivity (Simmonds et al., 2008; 
Criaud and Boulinguez, 2013), and emotional reactivity (Fusar-Poli et al., 2009). 
However, there is much variation in the specifics of fMRI tasks, even amongst those 
considered as ‘standard’, with meta-analyses often using relatively broad inclusion 
criteria. These have the advantage of increased statistical power at the expense of 
reduced specificity. Here we seek to establish not only the general neural correlates of 
the paradigms under investigation, but also those elicited by the specific forms of each 
task as they were implemented. 
 
Multi-Centre Studies 
 
The advantages of multi-centre study designs are numerous and well-rehearsed 
(Paterson et al., 2015). Their increased throughput is especially important in a platform 
study where the aim is to quickly establish if a treatment is effective so that decisions 
may be made on what investigations are to be carried out in the next iteration of the 
research program. Furthermore, the heterogeneous aetiology and clinical presentations 
of many disorders make extensive and widespread sampling of an affected population 
essential for proper characterisation. 
 
The involvement of multiple acquisition centres introduces new factors that require 
appropriate consideration during subsequent analysis. In particular, the overall variance 
is inflated by a between-centre factor and the potential for bias should a sub-set of 
centres have significantly greater statistical power than the others. 
 
 
In this paper we detail both the specific forms of the tasks used in the platform study, 
along with their modelling, sufficient to enable replication. Following this, and taking 
each task in turn, we establish their characteristics before investigating inter-centre 
differences.  
Methods 
 
The study was conducted in accordance with the Declaration of Helsinki. Ethical 
approval was obtained from West London & GTAC NRES committee and relevant 
Research Governance and PIC (Participant Identification Centre) approvals obtained. 
Data were collected at three UK centres: Imanova Limited, London; The Wolfson Brain 
Imaging Centre, University of Cambridge; Salford Royal NHS Foundation Trust, 
Manchester. 
 
Participants 
 
Out of the 155 participants who had a full baseline imaging session in the main ICCAM 
study, 68 were healthy controls with no history of drug or alcohol dependence (19, 33, 
and 16 from London, Cambridge, and Manchester respectively) – only this group is 
examined further here. These were recruited from healthy volunteer databases, via 
multimedia advertising including fliers, posters, social media, local newspapers, 
websites, homepage, and via word of mouth. 
 
From this group of 68 a subgroup of 43 (n = 15, 15, and 13 from London, Cambridge, 
and Manchester respectively) were chosen so that each centre had a similar distribution 
of gender and age. This group of 43 healthy individuals was used for both the task 
characterisation and inter-centre variability investigations. 
 
fMRI Task Protocols 
 
E-Prime 2.0 RC (version 2.0.8.90) was used to run all tasks. Tasks were adapted such 
that two runs of each (along with resting state and preliminaries) could be achieved 
within a one hour period. 
 
Monetary Incentive Delay Task 
 
The Monetary Incentive Delay task, designed to probe the reward sensitivity, was 
modified from Knutson et al. (2001). Participants could win or lose money depending 
upon how quickly they reacted to a target stimulus. The task contained win, loss and 
neutral trials. For the win trials, participants could win £0.50 if they responded quickly 
enough; for the loss trials, participants lost £0.50 if they did not respond quickly 
enough; and for the neutral trials participants neither won nor lost money. During each 
run, 216 volumes were collected, for a run length of 7 min 12 s. 
 
This task used an event related design, though with long mini-blocks, carried out in 2 
runs. Each run contained 18 win trials, 18 neutral trials, and 6 loss trials. In total, the 
task contained 36 win trials, 36 neutral trials and 12 loss trials. The task was set to 
obtain approximately 66% accuracy for the win trials. Furthermore, the task was 
designed to give an approximate winnings total of £10 (a perfect, though unlikely, result 
would result in winnings of £18). 
 
Participants were informed as to what trial they were about to perform via ‘cues’ that 
appeared on the screen for one second. Following the cues, there was an anticipation 
period (i.e. a black screen) before the target stimulus was presented. The duration of the 
anticipation period was randomly selected as 2, 3 or 4 s (with equal numbers of each 
period for each trial type). The anticipation period was immediately followed by the 
presentation of the target stimulus. The duration of the target stimulus differed 
depending upon the accuracy of participants. 
 
The starting duration for the win and neutral trials was 280 milliseconds (ms) for both 
runs (i.e. the time allowed for a participant to press the button after the stimulus was 
displayed). For the individualised algorithm, if a participant responded in time for the 
target stimulus, the target duration dropped by 10 ms (until the floor duration of 150 ms 
was reached). If the participants missed a trial, the target duration increased by 10 ms 
(until the ceiling duration of 300 ms was reached). The duration of each of the target 
symbols for each trial (win, neutral, loss) was contingent upon the participant’s 
accuracy for the same trial type only, i.e. win trial accuracy only affected stimulus 
duration of subsequent win trials, and not neutral or loss trials. Participants were 
informed if they were successful after each trial, together with a display of their total 
winnings, which was shown for 2 s. For each trial type the interval between the end of 
this information/winnings display, and the onset of the next cue were 2.4, 3.4, or 4.4 s, 
with equal numbers of each period across trial types. 
 
The starting duration for the loss trials was 240 ms for both runs. A reduced loss 
starting duration was chosen as we required participants to lose in order to increase the 
incentive salience of reward trials. A fixation cross was displayed for 12 s at the 
beginning of each run. 
 
Go/No-Go Task 
 
The Go/no-go task, designed to probe impulsivity, was modified from Garavan et al. 
(2002). Participants were presented with an alternating series of letter Xs and letter Ys 
and asked to respond as fast as they could to the appearance of each letter presented 
(‘go’ trial), except when the alternating sequence was broken by the appearance of a 
letter the same as that presented previously (‘no-go’ trial). During each run, 131 
volumes were collected, for a run length of 4 min 22 s. 
 
This task used an event related design and was carried out in 2 runs. Each run contained 
250 trials. 220 of these were ‘go’ trials where participants had to respond, and 30 of 
these trials were ‘no-go’ trials where the participant had to withhold a response (i.e. 
when the letter was the same as the previous letter). On average there was one ‘no-go’ 
trial every 8 s (range: 4 – 14 s). 
 
Each letter was presented on the screen for 900 ms and was followed by a 100 ms inter-
stimulus interval consisting of a blank screen. A fixation cross was displayed for 12 s at 
the beginning of each run. 
 
Evocative Images Task 
 
The Evocative Images task was designed to probe emotional reactivity. Participants 
were presented with aversive IAPS images containing scenes of injury or threat and 
neutral IAPS images containing scenes of animate and inanimate objects. Participants 
had to press their response pad to each image to ensure they were awake and attending 
to the images. During each run, 196 volumes were collected, for a run length of 6 min 
32 s. 
 
The task used a block design and was carried out in 2 runs. Each run contained 4 blocks 
of aversive images and 4 blocks of neutral images. Each block contained 6 images and 
each block was separated by a rest period to prevent carry-over effects. Images in each 
block were presented in a pseudorandomised order. The second run of the task 
contained the same images as the first run, but presented in a different order. Due to 
possible habituation effects, different images were presented at each session. 
 
Each block was 32.4 s (6 images of 5 s duration followed by a 400 ms inter-stimulus 
interval). Each rest period lasted 15 s. A fixation cross was displayed for 12 s at the 
beginning of each run. 
 
ALE Meta-Analyses 
 
To identify appropriate regions of interest (ROIs) for specific analyses, Activation 
Likelihood Estimation (ALE) meta-analyses (Eickhoff et al., 2009) of the literature 
were carried out using the BrainMap Project’s GingerALE version (2.3.1) for both the 
monetary incentive delay and go/no-go tasks. 
 The following general study selection criteria were applied: (i) participants’ mean age 
greater than 25 years (to preclude those studies focusing on young adults or children); 
(ii) used only one form of response (i.e. a single button for input); (iii) reported 
activation foci in either Talairach or MNI space; (iv) published in English; (v) appeared 
in a peer reviewed publication; (vi) used human participants; (vii) used greater than 6 
participants; (viii) published between January 2002 and April 2013. Only healthy 
control data used if a study included other groups. 
 
Monetary incentive delay studies were identified by searching the PubMed database 
using the terms: (‘monetary’ OR ‘money’ OR ‘anticipation’) AND (‘fMRI’ OR 
‘neuroimaging’); and by searching the BrainMap database (Fox et al., 2005) using the 
filters ‘fMRI’ and ‘reward’. In order to identify previous studies with comparable 
versions of the monetary incentive delay task examined here, these further criteria were 
used: (i) participants actually paid their winnings; (ii) loss trials present; (iii) more than 
10 gain trials; (iv) reward anticipation modelled against neutral anticipation. 
 
Go/no-go studies were identified by searching the PubMed database using the terms: 
(‘go/no-go’ OR ‘response inhibition’) AND (‘fMRI’ or ‘neuroimaging’); and by 
searching the BrainMap database using the filters ‘fMRI’ and ‘go/no-go’. In order to 
identify previous studies with comparable versions of the go/no-go task examined here, 
these further criteria were used: (i) no-go trials make up fewer than 40% of all trials; (ii) 
not include an oddball stimuli; (iii) use only letters (not images); (iv) use only 1 no-go 
cue; (v) correct no-go modelled against either correct go or an implicit baseline. 
 
For studies that reanalysed previously used data, only the original studies were used. All 
coordinates were transformed into MNI space as necessary. ALE was performed for 
each task with a False discovery rate (FDR) of p < 0.05 (corrected) and a minimum 
cluster volume of 600 mm3 (0.6 ml). 
 
For each task, an ROI was made up of two 5 mm radius spheres placed bilaterally such 
that they overlapped with the weighted centre coordinates of the strongest bilateral ALE 
clusters while robustly covering grey matter. 
 
Defining Regions of Interest: Evocative Images Task 
 
Although emotional imaging tasks have been used in many previous studies, the 
considerably variability in the design (especially in the specific images used within) 
precludes a meta-analysis using the criteria used for the other tasks here. We therefore 
selected the bilateral amygdala as a key region of interest, based on the previous 
literature with a range of emotional tasks (Phan et al., 2002). Thus, the ROI for the 
evocative images task was made up of two 5 mm radius spheres centred at the MNI co-
ordinates [±22, -4, -12 mm] so as to be robustly in the grey matter of the amygdala as 
defined functionally by the clusters reported in a previously published ALE meta-
analysis of amygdala responsivity (Costafreda et al., 2008). 
 
 
MRI Data Acquisition 
 
All centres operated MRI machines with a main magnetic field of 3 tesla (T). Centres in 
London and Cambridge operated nominally identical 3T Siemens Tim Trio systems 
running the syngo MR B17 software with a Siemens 32 channel receive-only phased-
array head coil. The Manchester centre operated a 3T Philips Achieva running version 
2.6.3.5 software and an 8 element SENSE head coil. 
 
At each visit the imaging session consisted of: localiser scans to set up the positioning 
of those that would follow; main magnetic field mapping; one run of resting state (360 
s); two runs of the monetary incentive delay task (432 s each); two runs of the go/no-go 
task (262 s each); two runs of the evocative images task (392 s each). 
 
The tasks were presented to participants in the same order in which they have been 
covered in this work, namely the two runs of the monetary incentive delay task, 
followed by the two runs of the go/no-go task, followed by the two runs of the 
evocative images task. This was so that performance of the monetary incentive delay 
task would not be adversely affected by a changed emotional state following the 
presentation of aversive images during the evocative images task. 
 
For each cohort, at the first visit only, a block of structural imaging was performed at 
the end of the session involving: a high resolution structural scan for anatomical 
registration and radiological reporting; a proton density scan to provide a second 
contrast for radiological reporting; a diffusion tensor imaging sequence for analysis of 
white matter. The resting state and diffusion tensor data will not be described further 
here, and will be described elsewhere. Structural images were used in spatial 
registration, but analysis of structural differences is not described here. 
 
Total in-scanner time was approximately 80 minutes at the first visit, and 60 minutes at 
all subsequent visits. At every visit, all tasks were practiced outside of the scanner 
immediately prior to the start of the imaging session. 
 
Structural Acquisition 
 At London and Cambridge (Siemens), high-resolution T1-weighted volumes were 
acquired using a magnetization-prepared rapid gradient echo (MPRAGE) sequence (TR 
= 2300 ms, TE = 2.98 ms, TI = 900 ms, flip angle = 9°, field of view = 256 mm, image 
matrix = 240 x 256) with a resolution of 1 mm isotropic. For the volume, 160 abutting 
straight sagittal slices were collected in an interleaved right to left manner, resulting in 
whole head coverage. Parallel imaging using Generalized Autocalibrating Partially 
Parallel Acquisition (GRAPPA) with an acceleration factor of 2 was performed. 
 
At Manchester (Philips), high-resolution T1-weighted volumes were also acquired using 
an MPRAGE sequence (TR = 6.8 ms, TE = 3.1 ms, TI = 900 ms, flip angle = 9°, field 
of view = 270 mm, image matrix = 256 x 256) with an in-plane resolution of 1.055 x 
1.055 mm and a slice thickness of 1.200 mm. For the volume, 126 abutting straight 
sagittal slices were collected in an interleaved right to left manner, resulting in whole 
head coverage. Parallel imaging using Sensitivity Encoding (SENSE) with an S 
reduction of 1.8 was performed. 
 
These T1-weighted volumes followed ADNI protocols (Jack et al., 2008) to minimise 
inter-centre differences. 
 
Functional Acquisition 
 
At London and Cambridge (Siemens), functional imaging was performed using a multi-
echo gradient echo echoplanar imaging (EPI) sequence (TR = 2000 ms, TE = 13 & 31 
ms, flip angle = 80°, field of view = 225 mm, image matrix = 64 x 64) with an in-plane 
resolution of 3.516 x 3.516 mm and a slice thickness of 3.000 mm. The phase encoding 
direction was anterior to posterior. Echo spacing was 0.52 ms. 
 
For each volume, 36 abutting oblique axial slices were collected in an ascending 
manner at an angle of around 30° to the anterior (AC) and posterior commissure (PC) 
line. This results in slightly less than whole brain coverage, with the most superior 9 
mm not being imaged in most participants. 
 
To achieve the desired resolution and repetition time, parallel imaging using GRAPPA 
with an acceleration factor of 2 was performed. The first three volumes of each 
functional run were automatically discarded to allow for T1 saturation effects and are 
not included in any number of volumes reported here. 
 
At Manchester (Philips) identical parameters were used for EPI acquisition, but with 34 
slices being collected and with acceleration achieved using SENSE. 
 Data Processing 
 
Structural and functional processing was carried out using Analysis of Functional 
NeuroImages (AFNI) (version AFNI_2011_12_21_1014), FreeSurfer (version 
freesurfer-x86_64-unknown-linux-gnu-stable5-20130513), Advanced Normalization 
Tools (ANTs) (version ANTs-1.9.v4-Linux), and FMRIB Software Library’s (FSL) 
(version 5.0.6) FMRI Expert Analysis Tool (FEAT) (version 6.00). All were run on 
CentOS 6.5 (version centos-release-6-5.el6.centos.11.2.x86_64). 
 
T1 images were first corrected for intensity non-uniformity (AFNI’s 3dUniformize) 
before having extracerebral tissues removed (as part of FreeSurfer’s recon-all pipeline). 
The whole brain images were then non-linearly registered to the MNI ICBM152 non-
linear 6th generation symmetric average brain stereotaxic registration model in a 2 mm 
isotropic voxel space (ANTs’ antsRegistration). 
 
EPIs were corrected for slice timing effects (AFNI’s 3dTshift) before each volume was 
registered (AFNI’s 3dvolreg) to the volume most similar, in the least squares sense, to 
all others (in-house code). For each task a summary of movement was recorded as the 
speed of motion over the runs (i.e. the sum of framewise displacements (FD) over the 
time taken for the runs, measured in mm/s). 
 
The residual extracerebral tissues were then removed using FSL’s Brain Extraction Tool 
(BET). Linear registration to the T1 image was achieved through a Boundary Based 
Registration (BBR) approach (FSL’s epi_reg) before combining transformations to 
bring the EPIs into the same standard stereotaxic space as the transformed T1 (ANTs’ 
antsApplyTransforms). Finally, these were smoothed with a three-dimensional Gaussian 
kernel of full width at half maximum of 6.0 mm (i.e. standard deviation = 2.5 mm) 
(AFNI’s 3dBlurInMask). 
 
fMRI Task Modelling 
 
Task processing and modelling was carried out using E-Prime (version 2.0.8.90), 
Microsoft Office Excel 2007 (version 12.0.4518.1014), in-house Python (version 2.7.6) 
scripts, and FSL. 
 
Data from task responses were processed into usable formats (E-Prime’s E-DataAid) 
before behavioural data and timings were extracted (Excel) and processed further 
(Python scripts) into 3-column-format text files for each event type for compatibility 
with FEAT. 
 
FMRIB’s Improved Linear Modelling (FILM) prewhitening was performed on all voxel 
time courses. Estimates of six motion parameters (translations in the three orthogonal 
directions along with pitch, roll and yaw) calculated during preprocessing (AFNI’s 
3dvolreg) were included in each model as confounding explanatory variables. 
 
In all models convolution with a haemodynamic response function (HRF) was 
performed, this being FSL’s commonly used gamma function with standard deviation 3 
s and mean lag 6 s. No temporal derivatives were used in any model. All models had the 
same temporal filtering applied to them as was done to the image data. 
 
Monetary Incentive Delay Task 
 
Nine explanatory variables were used for modelling the task itself. These were the three 
different general conditions – reward, neutral, or loss – with each of these having three 
potential phases – anticipation, successful outcome, or unsuccessful outcome. 
‘Anticipation’ was modelled as a block beginning at the cue (an arrow or line) onset and 
ending at the trial (a star) onset (these blocks lasting between approximately 3 s and 5 
s). ‘Outcome’ was modelled as an immediately abutting block beginning at the trial (a 
star) onset and ending two seconds later. A high-pass filter cutoff of periods above 50 s 
was applied to both the data and the model. The contrast further explored in this work is 
that of ‘reward anticipation’ compared with ‘neutral anticipation’, with ‘reward 
anticipation’ being expected to show greater BOLD response (Knutson et al., 2001). 
 
Go/No-Go Task 
 
Two explanatory variables were used for modelling the task itself, one for ‘successful 
no-go’ and the other for ‘unsuccessful no-go’. These were modelled against an implicit 
baseline of ‘go’. Both ‘successful no-go’ and ‘unsuccessful no-go’ were modelled as 
events lasting 0.1 s. A high-pass filter cutoff of periods above 120 s was applied to both 
the data and the model. The contrast further explored in this work is that of ‘successful 
no-go’ compared with the implicit baseline of ‘go’, with ‘successful no-go’ being 
expected to show greater BOLD response (Garavan et al., 2003: 2003). 
 
Evocative Images Task 
 
Two explanatory variables were used for modelling the task itself, one for ‘aversive’ 
images and the other for ‘neutral’ images. Both ‘aversive’ and ‘neutral’ were modelled 
as blocks lasting 32.4 s. A high-pass filter cutoff of periods above 100 s was applied to 
both the data and the model. The contrast further explored in this work is that of 
‘aversive’ compared with ‘neutral’ images, with ‘aversive’ images being expected to 
show greater BOLD response (Asensio et al., 2010). 
 
Higher Level Analysis 
 
FEAT was used to run all the models discussed above within a general linear model 
framework. As each task was run twice in each imaging session the mean of the results 
for both runs was used in all higher level analyses. 
 
This voxelwise analysis was extended to a group level in a mixed-effects analysis using 
FSL’s FLAME 1 (1-sample t-test) controlling for centre, age, and sex. In calculating the 
whole brain group maps as part of the task characterisation investigation, data from the 
baseline session of the 43 inter-centre participants were used (a between-centre factor 
was included in the model). The Z statistic images shown in this work for the evocative 
and go/no-go tasks were thresholded using clusters determined by Z > 3.1 (i.e. an initial 
uncorrected cluster forming threshold of p < 0.001) and a (corrected) cluster 
significance threshold of p < 0.05. These initial cluster thresholds are higher than those 
commonly seen, and follow the advice given by Woo et al. (2014) relating to minimum 
valid thresholds. The equivalent images for the monetary incentive delay task were 
thresholded using clusters determined by Z > 4.5 and a (corrected) cluster significance 
threshold of p < 0.05. This initial cluster threshold was raised compared with the other 
tasks due to the relatively stronger response expected in comparison to the other tasks, 
so that clusters would still be able to form and be interpretable. This group analysis was 
performed on the whole brain, insofar as including all those voxels which all 
participants had in common (areas outside this common coverage are shown masked in 
figures). 
 
For the tasks which have temporal characteristics similar to block designs (monetary 
incentive delay and evocation) the contrasts’ mean percentage signal changes within 
their ROIs were calculated (FSL’s Featquery), while for the fast event-related design 
(go/no-go) arbitrary units based on the parameter estimates were used as percentage 
signal change is not usefully interpretable in this case. 
 
Inter-Centre Differences 
 
Non-image statistical analysis was carried out using IBM SPSS Statistics (version 22.0). 
When appropriate, values are given as mean ± standard deviation. 
 
Between centre differences were tested for using one-way analysis of variance 
(ANOVA). When significant differences were found between centres Tukey’s honestly 
significant difference (HSD) was used as the post-hoc test. Heterogeneity of variance 
was examined using Levene’s test, and if found to be significant (p < 0.05) Welch’s F 
was used. Post-hoc testing for data not meeting the homogeneity of variance assumption 
was carried out using the Games Howell method. Normality of data from each centre 
was tested using the Shapiro-Wilk method, and, if found to be significantly (p < 0.05) 
skewed, a non-parametric Kruskal-Wallis test performed in place of an ANOVA. Post-
hoc tests for data examined using a non-parametric approach were carried out using the 
Mann-Whitney U test. All reported p values are those before any correction for either 
the number of tasks, or the number of tests carried out on the behavioural and summary 
imaging measures of those tasks, but they have been corrected for the number of post-
hoc tests carried out for a particular measure. 
 
FEAT was used to perform a voxelwise ANOVA, examining between centre 
differences to produce F statistic images of the whole brain for each task. 
 
  
Results 
 
Participants 
 
A summary of the groupings and participant information is given in Table 1. No 
differences were found between centres for age, sex, or handedness, consistent with the 
matching process. 
 
 
Each of the three tasks - monetary incentive delay, go/no-go, and evecative images - 
will be fully covered in turn, with each broken down into its meta-analysis/ROI, task 
characterisation, and inter-cetre differences. 
  
Monetary Incentive Delay - ALE Meta-Analysis 
 
For the monetary incentive delay task, we identified an initial total of 487 studies from 
searches on PubMed, and 170 from the BrainMap database, with 156 of the latter being 
duplicates of the former. This left a total of 501 studies. After abstract screening (501 
studies) and full-text review (90 studies), 17 studies remained, representing 292 healthy 
participants with a total of 170 activation foci, shown in Table 2. Four clusters were 
found after carrying out the ALE analysis, the two largest of these being focused on the 
anterior region of the left and right putamen and overlapping with portions of caudate, 
nucleus accumbens, and globus pallidus (all bilaterally). All clusters found through 
ALE analysis are listed in Supplementary Table 1 and are shown in Figure 1. The ROI 
for this task was made up of bilateral 5 mm radius spheres centred at the co-ordinates 
([L-R, P-A, I-S] in MNI space) [±14, 12, -4 mm], i.e. striatum (dorsal 
putamen/caudate). 
 
Monetary Incentive Delay - Task Characterisation 
 
Accuracy was not found to be different between the three types of trial (reward, neutral, 
and loss) (F2,126 = 1.33, p = 0.27), although response time was (F2,126 = 4.31, p = 0.015), 
with response time of neutral trials being slower than loss trials (p = 0.003). 
Supplementary Table 6 lists behavioural results. 
 
The strongest observed response to reward anticipation (in terms of Z statistics) was in 
the primary visual cortex, with other strong responses in the caudate and anterior insula 
bilaterally. A spatially widespread response was observed in other visual areas and a 
large group of regions incorporating the striatum, thalamus, and insula, along with 
motor areas. No regions were seen to have a stronger response to neutral anticipation. 
Whole brain summary images of the reward anticipation > neutral anticipation contrast 
are shown in Figure 2, while more detailed images are shown in Supplementary Figure 
1. Supplementary Table 3 lists the locations of clusters larger than 2 ml. 
 
For this contrast, in the striatal ROI, the mean response (n = 43) was 0.53% ± 0.05 with 
a mean Z statistic of 5.84 ± 0.31. Supplementary Table 6 lists ROI results. 
 
Monetary Incentive Delay - Inter-Centre Differences 
 
In the monetary incentive delay task the accuracy of loss trials was different between 
the centres (Kruskal-Wallis, p = 0.006), with Manchester having lower accuracy than 
Cambridge (Mann-Whitney, p = 0.007). The response time of successful loss trials was 
different between the centres (Kruskal-Wallis, p = 0.004), with Manchester being 
slower than Cambridge (Mann-Whitney, p = 0.012). Three of the other measures for the 
monetary incentive delay task – amount won, reward accuracy, and neutral accuracy – 
had skewed distributions (Shapiro-Wilk test) and so a non-parametric (Kruskal-Wallis) 
test was performed (p = 0.01, 0.04, and 0.03 respectively). These do not survive at the α 
= 0.05 level after a Bonferroni correction for the number of tests performed on the 
behavioural measures of this task (approximately seven independent tests), but are 
reported here for completeness. Appropriately corrected Mann-Whitney U post-hoc 
tests reveal that Manchester participants won less than those in London (p = 0.009), and 
had lower accuracy at reward trials than those in London (p = 0.021). 
 
No imaging differences were found between centres at the whole brain (voxelwise) 
level. Unthresholded F maps are shown in Figure 5. 
 
No differences were found between centres with regard to the ROI results. 
 
 
 
 
  
Go/No-Go - ALE Meta-Analysis 
 
For the go/no-go task, we identified an initial total of 353 studies from searches on 
PubMed, and 94 from the BrainMap database, with 80 of the latter being duplicates of 
the former. This left a total of 367 studies. After abstract screening (367 studies) and 
full-text review (189 studies), 12 studies remained, representing 243 healthy 
participants with a total of 180 activation foci, shown in Table 3. 12 clusters were found 
after carrying out the ALE analysis, distributed around the brain, but with a 
concentration around the striatum. All clusters found through ALE analysis are listed in 
Supplementary Table 2 and are shown in Figure 1. The ROI for this task was made up 
of bilateral 5 mm radius spheres centred at the co-ordinates [±22, 8, 6 mm], i.e. striatum 
(dorsal putamen). 
 
Go/No-Go - Task Characterisation 
 
Response time was found to be different between successful ‘go’ and unsuccessful ‘no-
go’, with faster button presses for unsuccessful ‘no-go’ (t = 6.69, p < 0.0001, df = 42). 
Supplementary Table 7 lists behavioural results. 
 
The strongest observed response to successful no-go (in terms of Z statistics) was in the 
anterior insula bilaterally, with other strong responses in right inferior frontal gyrus, 
putamen and thalamus. A spatially widespread response was observed across the brain, 
including right dorsolateral prefrontal cortex and bilateral motor areas. Only 
ventromedial prefrontal cortex was observed to have greater response to ‘go’ (implicit 
baseline). Whole brain summary images of the successful no-go > go (implicit baseline) 
contrast are shown in Figure 3, while more detailed images are shown in Supplementary 
Figure 2. Supplementary Table 4 lists the locations of clusters larger than 2 ml. 
 
For this contrast, in the striatal ROI, the mean response (n = 43) was 0.36 arbitrary units 
± 0.06 with a mean Z statistic of 6.27 ± 0.47. Supplementary Table 7 lists ROI results. 
 
Go/No-Go - Inter-Centre Differences 
 
No behavioural differences were found between centres for the go/no-go task. 
 
No imaging differences were found between centres at the whole brain (voxelwise) 
level. Unthresholded F maps are shown in Figure 5. 
 
No differences were found between centres with regard to the ROI results.  
Evocative Images - Task Characterisation 
 
Although the range of response times was large (280 to 1373 ms for neutral images and 
267 to 1651 for aversive images) there was a very strong correlation between the two 
times (r = 0.94, p < 0.00001, df=58). The difference in response time (21 ms) was not 
significant between the aversive and neutral images (t = 1.86, p = 0.068, df = 42). 
Supplementary Table 8 lists behavioural results. 
 
The strongest response observed to aversive images (in terms of Z statistics) was in 
visual cortex, with the strongest response outside of this region being in the amygdala 
bilaterally. Strong response was also observed in thalamus and medial hippocampus. 
Greater response to neutral images was observed in prefrontal and auditory cortices. 
Whole brain summary images of the aversive images > neutral images contrast are 
shown in Figure 4, while more detailed images are shown in Supplementary Figure 3. 
Supplementary Table 5 lists the locations of clusters larger than 2 ml. 
 
For this contrast, in the amygdala ROI, the mean response (n = 43) was 0.32% ± 0.09 
with a mean Z statistic of 3.90 ± 1.06. Supplementary Table 8 lists ROI results. 
 
Rate of motion (i.e. mm/s) was not found to differ significantly for different tasks (F2,126 
= 2.61, p = 0.08). 
 
Evocative Images - Inter-Centre Differences 
 
No behavioural differences were found between centres for the evocative images task. 
 
No imaging differences were found between centres at the whole brain (voxelwise) 
level. Unthresholded F maps are shown in Figure 5. 
 
In the evocative images task, mean response (percentage signal change) within the 
amygdala ROI was found to differ between the centres (F2,40 = 5.06, p = 0.01), along 
with, as one would expect given the signal change, the mean Z statistic in this region 
(F2,40 = 5.98, p = 0.005). This was due to the Manchester participants having a lower 
response for this aversive images > neutral images contrast. 
 
 
 
 
  
Discussion 
 
We report here the establishment of an fMRI platform, ICCAM, to study mechanisms 
of relevance to relapse in addiction. Across three tasks investigating reward sensitivity, 
inhibitory control, and emotional reactivity, we have examined their characteristics, and 
inter-centre differences for behavioural, whole brain, and ROI measures. This study 
raised a number of issues, which we now discuss in turn. 
 
Importantly our three tasks resulted in the expected pattern of brain responses consistent 
with existing evidence. Thus the monetary incentive delay task resulted in responses in 
regions such as the visual cortex, striatum, prefrontal and insula cortices consistent with 
previous studies (Knutson et al., 2001). The influence of variations in the task on the 
patterns of brain responses have been described elsewhere (Hommer et al., 2011; 
Limbrick-Oldfield et al., 2013). Though many people use the monetary incentive delay 
task, most adapt it to some extent so that it is no longer a standardised task. For 
instance, the ICCAM version of the monetary incentive delay task prioritized imaging 
‘anticipation of reward’ since this primary contrast has been found altered in addiction 
and is of relevance to relapse. Therefore we were less interested in brain responses to 
loss or outcomes. 
 
The pattern of brain response elicited by our monetary incentive delay task was 
consistent with that derived from the meta-analysis. Many fMRI studies of the monetary 
incentive delay task used spatially constrained approaches, i.e. analyses perform within 
ROIs of varying size, focused on striatal regions. Out of the 17 studies used here, 11 
were not ‘whole brain’ analyses. Indeed, in the original fMRI monetary incentive delay 
study (Knutson et al., 2001), a limited acquisition of coronal slices was used, limiting 
coverage to a block including the striatum, and our own coverage is itself limited as can 
be seen throughout the figures (such as Figure 2). By comparison, of the 12 go/no-go 
studies included in the meta-analysis, none used such a spatially constrained approach. 
 
The responses to the go/no-go task in inferior frontal gyrus, striatum, insula and 
thalamus were consistent with previous studies (Steele et al., 2013; Luijten et al., 2014). 
Our meta-analysis of similar go-nogo tasks resulted in a striatal ROI though this was 
more dorsal than the one derived from the meta-analysis of the monetary incentive 
delay task. This association between ventral striatum associated with reward processing 
and dorsal striatum with habit or compulsive behaviours, and the importance of fronto-
corticostriatal loops in inhibitory control have been well documented (Everitt and 
Robbins, 2005; Koob and Volkow, 2010). 
 
Although there is often a focus on the inferior frontal gyrus (IFG) when discussing 
go/no-go tasks, it did not emerge in our ALE meta-analysis (which closely follow the 
results presented in the task characterisation here). IFG response was observed in our 
task, though was weaker than insular or striatal responses. This might be explained by 
the ‘simple’ design task used here (and thus the strict criteria in our meta-analysis) 
while the majority of those in the literature used more complex designs (Criaud and 
Boulinguez, 2013). In the extensive ALE meta-analysis performed by Criaud and 
Boulinguez (2013) examining several facets of fMRI go/no-go tasks, it is also suggested 
that typical no-go activity is mostly driven by attention, not inhibition, though this is 
still a current topic of debate (Aron et al., 2014). 
 
Both the go-nogo and monetary incentive delay task resulted in robust responses in the 
insula, particularly anterior insula. This brain region has been shown to be involved in 
self-regulation and reward seeking as well as in emotional awareness through 
integrating sensory information into cognitive, affective and physiological processes, 
along with being part of a task general network (Nelson et al., 2010; Menon and Uddin, 
2010; Gu et al., 2013). With regard to addiction, the insula appears also to be involved 
with critical functions such as craving and the landmark description that damage to its 
structure substantially increased the likelihood of smoking cessation (Naqvi and 
Bechara, 2009; Garavan, 2010). 
 The evocative images task produced a robust response in the dorsal amygdala, along 
with inferior portions of the globus pallidus, with the highest response near the 
amygdala overlapping with the predetermined amygdala ROI. Such a pattern is 
consistent with previous studies using an evocative task or one that requires emotional 
processing (Costafreda et al., 2008; Sergerie et al., 2008). We were particularly 
interested in demonstrating a robust response in the amygdala since dysregulation in 
this region is implicated in relapse vulnerability in addiction, in particular those 
involving stress (Koob et al., 2014). 
 
Even though this comparison between centres did not utilize a travelling participants 
design such as those of (Friedman et al., 2008; Suckling et al., 2012; Gee et al., 2015), it 
demonstrates that different groups of participants at different centres produce markedly 
similar responses to the tasks in our ICCAM platform. Recent explorations of both 
functional and structural neuroimages acquired from multiple centres have 
unequivocally demonstrated high levels of within- and between-centre reliability as well 
as small between-centre variances relative to the total variance (Suckling et al., 2012; 
Gee et al., 2015). 
 
However, the lack of significant whole brain differences in the participants examined 
here does not necessarily imply that with larger groupings and different patient 
populations there would not be differences observed. 
 
Although much effort was made to run the study in as similar a manner possible at each 
centre, there were inevitably slight differences between the experimental setups. From 
the voxelwise F statistic images in the Evocative Images task (Figure 5) a trend to a 
center difference was focused around the amygdala and was driven by the Manchester 
group. One factor may have been the means by which images were projected, which 
was almost identical in London and Cambridge but differed in Manchester where 
images were projected in a different manner, creating a less bright image and so 
possibly less salient, creating a smaller difference in activity between the aversive and 
neutral images. 
 
Although in this analysis we have explored differences between centres, in the patient 
study itself participants were recruited so that there would be a roughly equal proportion 
of cases to controls at each centre, with centre also being included as a covariate in all 
analyses. Centre was also used as a covariate in the characterisation of the tasks. 
 
Conclusion 
 We have demonstrated here the establishment of an fMRI platform involving three 
different tasks, repeated at multiple sessions and at three different centres. The 
establishment of this platform was critical to provide a framework to explore three key 
processes in the neurobiology of relapse vulnerability in addiction: reward; inhibitory 
control; and emotional regulation. This allows for an evidence base to inform future 
development in treatment to be provided within reasonable time periods. Future papers 
will present the results of these tasks in our healthy and patient groups, and under 
pharmacological modulation. 
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TABLE 1. 
 
Participant information    
 London Cambridge Manchester ANOVA / Chi-square Combined 
 (n=15) (n=15) (n=13) (n=15,15,13) (n=43) 
Age (years) 40.5 ± 8.5 (21-
53) 
37.9 ± 9.3 (22-
52) 
41.0 ± 9.3 (25-
56) 
F2,40 = 0.50, p = 0.61 39.7 ± 8.9 (21-
56) 
# female 3 3 3 X2(2, N = 43) = 0.05, p = 0.97 9 
# left handed 
/ambidextrous 
4/1 4/1 0/2 X2(4, N = 43) = 4.61, p = 0.33 8/4 
 
  
TABLE 2. 
Studies included in the Monetary Incentive Delay ALE meta-analysis 
Year 
 
Author 
 
Participants 
 
Foci 
 
Design 
 
Scanner 
strength (T) 
Whole brain 
analysis 
2003 Knutson B et al. 12 10 Knutson 1.5 No 
2004 Knutson B et al. 8 8 Knutson 3 Yes 
2006 Juckel G et al. 10 9 Knutson 1.5 No 
2007 Wrase J et al. 14 18 Knutson 1.5 No 
2007 Wrase J et al. 16 2 Knutson 1.5 No 
2008 Knutson B et al. 12 8 Knutson 1.5 Yes 
2008 Schlagenhauf F et al. 10 12 Knutson 1.5 No 
2008 Schmack K et al. 44 2 Knutson 1.5 No 
2008 Strohle A et al. 10 7 Knutson 1.5 No 
2009 Beck A et al. 19 6 Knutson 1.5 No 
2010 Bjork JM et al. 24 10 Bjork 3 No 
2011 de Greck M et al. 20 12 Knutson 1.5 Yes 
2012 Balodis IM et al. 14 7 Knutson 3 No 
2012 Cho YT et al. 30 18 Knutson 3 Yes 
2012 Enzi B et al. 19 15 Knutson 1.5 Yes 
2013 Edel MA et al. 12 4 Knutson 1.5 No 
2013 Saji K et al. 18 22 Knutson 1.5 Yes 
 
Total 292 170 
    
  
TABLE 3. 
Studies included in the Go/no-go ALE meta-analysis 
Year Author Participants Foci Design 
Scanner 
strength (T) 
Whole brain 
analysis 
2002 Garavan H et al. 14 16 X/Y Alternating 1.5 Yes 
2003 Garavan H et al. 16 7 X/Y Alternating 1.5 Yes 
2004 Hester R et al. 15 21 X/Y Alternating 1.5 Yes 
2004 Kelly AM et al. 15 23 X/Y Alternating 1.5 Yes 
2005 Maltby N et al. 11 5 X is Go, K is Nogo 1.5 Yes 
2007 Epstein JN et al. 9 15 Multiple Go Cues, X is Nogo 1.5 Yes 
2009 Welander-Vatn AS et al. 28 12 Multiple Go Cues, V is Nogo 1.5 Yes 
2012 Bannbers E et al. 14 2 X/Y Alternating 3 Yes 
2012 Sebastian A et al. 24 19 Multiple Go Cues, X is Nogo 3 Yes 
2013 Sebastian A et al. 49 26 Multiple Go Cues, X is Nogo 3 Yes 
2013 Sebastian A et al. 24 25 Multiple Go Cues, X is Nogo 3 Yes 
2013 van der Salm SMA et al. 24 9 X/Y Alternating 3 Yes 
 
Total 243 180 
    
 
FIGURE 1. 
Clusters found through the Activation Likelihood Estimation (ALE) meta-analyses. ALE was 
performed for each task with a False discovery rate (FDR) of p < 0.05 (corrected) and a minimum 
cluster volume of 0.6 ml. 
 
 
  
FIGURE 2.  
The contrast of reward anticipation with neutral anticipation in the monetary incentive delay task in the 
combined group (n = 43), controlling for centre, age, and sex. Images were thresholded using clusters 
determined by Z > 4.5 and a (corrected) cluster significance threshold of p < 0.05. The slices shown 
were chosen such that all three intersect with the left side of the ROI used later in this work. The 
greyed out portion shows areas outside common coverage. 
 
 
  
FIGURE 3.  
The contrast of successful no-go with go (implicit baseline) in the go/no-go task in the combined group 
(n = 43), controlling for centre, age, and sex. Images were thresholded using clusters determined by Z 
> 3.1 and a (corrected) cluster significance threshold of p < 0.05. The slices shown were chosen such 
that all three intersect with the left side of the ROI used later in this work. The greyed out portion 
shows areas outside common coverage. 
 
 
FIGURE 4.  
The contrast of aversive images with neutral images in the evocative images task in the combined 
group (n = 43), controlling for centre, age, and sex. Images were thresholded using clusters determined 
by Z > 3.1 and a (corrected) cluster significance threshold of p < 0.05. The slices shown were chosen 
such that all three intersect with the left side of the ROI used later in this work. The greyed out portion 
shows areas outside common coverage. 
 
 
 
  
FIGURE 5. 
Unthresholded F maps exploring inter-centre differences. No significant imaging differences were 
found between centres at this whole brain (voxelwise) level. 
 
 
 
 
 
 
  
SUPPLEMENTARY MATERIALS 
 
 
SUPPLEMENTARY TABLE 1. 
 
Monetary incentive delay: reward anticipation > neutral anticipation 
17 experiments, 296 subjects 
Region Cluster 
volume (ml) 
Weighted centre MNI 
coordinates (mm) 
x y z 
Right Putamen 7.60 15 9 -4 
Left Putamen 6.91 -15 9 -6 
Right Anterior Insula 0.94 33 23 -4 
Left Inferior Frontal Precentral Gyrus 0.94 -50 9 28 
 
Clusters are named according to the structure with the highest probability at that position in the 
Harvard-Oxford Cortical and Subcortical Structural Atlases. 
  
SUPPLEMENTARY TABLE 2. 
 
Go/no-go: successful no-go > go 
12 experiments, 246 subjects 
Region Cluster 
volume (ml) 
Weighted centre MNI 
coordinates (mm) 
x y z 
Right Frontal Pole 2.77 35 40 24 
Left Putamen 2.20 -20 7 4 
Right Supplementary Motor Area 1.73 1 -1 63 
Supramarginal Gyrus 1.49 49 -38 44 
Superior Temporal Gyrus 1.34 56 -27 -2 
Right Occipital Pole 1.33 30 -90 9 
Precentral Gyrus 1.22 -45 -4 50 
Right Lateral Occipital Cortex 1.20 31 -62 52 
Right Putamen 0.82 21 6 6 
Left Lateral Occipital Cortex 0.74 -50 -75 3 
Right Lateral Occipital Cortex 0.70 48 -72 -2 
Left Lateral Occipital Cortex 0.66 -22 -63 54 
 
Clusters are named according to the structure with the highest probability at that position in the 
Harvard-Oxford Cortical and Subcortical Structural Atlases. 
 
 
 
 
  
SUPPLEMENTARY FIGURE 1. 
A detailed view of the contrast shown in Figure 2. The contrast of reward anticipation with neutral 
anticipation in the monetary incentive delay task in the combined group (n = 43), controlling for centre, 
age, and sex. Images were thresholded using clusters determined by Z > 4.5 and a (corrected) cluster 
significance threshold of p < 0.05. The greyed out portion shows areas outside common coverage. 
 
 
 
SUPPLEMENTARY TABLE 3. 
 
Monetary incentive delay: reward anticipation > neutral anticipation 
Region Cluster 
volume 
(ml) 
p Local 
maxima 
Z score 
MNI 
coordinates of 
maxima (mm) 
x y z 
Cluster 1 (Occipital Lobe) 185 < 0.0001     
   Lateral Occipital Cortex, inferior division   7.05 48 -78 -6 
   Lingual Gyrus   6.97 -48 -66 4 
   Occipital Pole   6.94 -18 -98 2 
   Occipital Fusiform Gyrus   6.92 18 -90 -10 
   Occipital Pole   6.57 18 -94 -14 
   Cerebellum   6.55 18 -58 -52 
Cluster 2 (Frontal Lobe) 175 < 0.0001     
   Inferior Frontal Gyrus, pars opercularis   6.92 58 12 6 
   Frontal Operculum Cortex   6.92 32 30 8 
   Frontal Orbital Cortex   6.60 30 32 2 
   Supramarginal Gyrus, anterior division   6.60 56 -32 36 
   Cingulate Gyrus, anterior division   6.59 -28 30 4 
   Thalamus   6.58 8 -14 16 
Cluster 3 (Frontal Lobe) 2.76 < 0.0001     
   Paracingulate Gyrus   5.87 -34 40 34 
   Superior Frontal Gyrus   5.14 -32 38 44 
   Paracingulate Gyrus   4.83 -34 50 18 
Cluster 4 (Parietal Lobe) 2.08 < 0.0001     
   Postcentral Gyrus   5.68 32 -38 42 
   Postcentral Gyrus   5.66 38 -38 42 
   Postcentral Gyrus   4.84 42 -26 38 
 
Coordinates (in MNI space) and Z score maxima for cluster-based statistical contrasts (all Z > 4.5, p < 
0.05). Only clusters larger than 2 ml are shown. Clusters are first named by their general position 
according to the Talairach Daemon, while maxima are named according to the structure with the 
highest probability at that position in the Harvard-Oxford Cortical and Subcortical Structural Atlases.  
 SUPPLEMENTARY FIGURE 2. 
A detailed view of the contrast shown in Figure 3. The contrast of successful no-go with go (implicit 
baseline) in the go/no-go task in the combined group (n = 43), controlling for centre, age, and sex. 
Images were thresholded using clusters determined by Z > 3.1 and a (corrected) cluster significance 
threshold of p < 0.05. The greyed out portion shows areas outside common coverage. 
 
 
 
SUPPLEMENTARY TABLE 4. 
 
Go/no-go: successful no-go > go (implicit baseline) 
Region Cluster 
volume 
(ml) 
p Local 
maxima 
Z score 
MNI 
coordinates of 
maxima (mm) 
x y z 
Cluster 1 (Sub-lobar) 371 < 0.0001     
   Insular Cortex   9.34 32 18 6 
   Subcallosal Cortex   8.38 -32 14 8 
   Supramarginal Gyrus, posterior division   8.34 60 -44 26 
   Superior Temporal Gyrus, posterior division   8.23 48 -28 -2 
   Inferior Frontal Gyrus, pars opercularis   8.02 48 8 10 
   Precentral Gyrus   7.81 50 8 6 
Cluster 2 (Frontal Lobe) 9.2 < 0.0001     
   Paracingulate Gyrus   5.97 -34 46 28 
   Paracingulate Gyrus   5.36 -30 54 20 
   Frontal Pole   5.20 -38 56 14 
   Paracingulate Gyrus   4.54 -36 46 16 
Cluster 3 (Limbic Lobe) 3.096 0.0001     
   Frontal Medial Cortex   -4.48 -10 50 -12 
   Frontal Medial Cortex   -4.42 12 46 -10 
   Frontal Medial Cortex   -4.21 4 48 -14 
   Paracingulate Gyrus   -4.14 6 36 -12 
   Frontal Medial Cortex   -3.99 -2 54 -8 
   Subcallosal Cortex   -3.40 -8 30 -8 
 
Coordinates (in MNI space) and Z score maxima for cluster-based statistical contrasts (all Z > 3.1, p < 
0.05). Only clusters larger than 2 ml are shown. Clusters are first named by their general position 
according to the Talairach Daemon, while maxima are named according to the structure with the 
highest probability at that position in the Harvard-Oxford Cortical and Subcortical Structural Atlases. 
 
  
 SUPPLEMENTARY FIGURE 3. 
A detailed view of the contrast shown in Figure 4. The contrast of aversive images with neutral images 
in the evocative images task in the combined group (n = 43), controlling for centre, age, and sex. 
Images were thresholded using clusters determined by Z > 3.1 and a (corrected) cluster significance 
threshold of p < 0.05. The greyed out portion shows areas outside common coverage. 
 
 
 
  
SUPPLEMENTARY TABLE 5. 
 
Evocative images: aversive images > neutral images 
Region Cluster 
volume 
(ml) 
p Local 
maxima 
Z score 
MNI 
coordinates of 
maxima (mm) 
x y z 
Cluster 1 (Occipital Lobe) 182 < 0.0001     
   Lateral Occipital Cortex, inferior division   8.83 48 -74 -2 
   Occipital Fusiform Gyrus   8.81 30 -78 -12 
   Lateral Occipital Cortex, inferior division   8.81 52 -70 6 
   Occipital Pole   8.74 18 -94 18 
   Lingual Gyrus   8.72 -20 -84 -10 
   Occipital Pole   8.69 -4 -92 -6 
Cluster 2 (Frontal Lobe) 69.8 < 0.0001     
   Frontal Pole   -6.71 34 50 10 
   Paracingulate Gyrus   -6.13 -34 54 8 
   Frontal Medial Cortex   -5.73 -26 52 -8 
   Middle Frontal Gyrus   -5.67 30 28 32 
   Paracingulate Gyrus,   -5.60 -32 46 8 
   Left Cerebral White Matter   -5.54 22 40 -4 
Cluster 3 (Sub-lobar) 28.5 < 0.0001     
   Amygdala   6.36 -20 -6 -12 
   Thalamus   6.22 -20 -30 0 
   Brain-Stem   6.17 -6 -30 -6 
   Amygdala   6.01 24 -4 -14 
   Thalamus   5.77 22 -30 0 
   Brain-Stem   5.65 4 -32 -2 
Cluster 4 (Temporal Lobe) 19.8 < 0.0001     
   Planum Temporale   -5.74 62 -22 6 
   Planum Temporale   -5.67 52 -30 12 
   Superior Temporal Gyrus, posterior division   -5.66 64 -22 2 
   Parietal Operculum Cortex   -5.48 50 -32 18 
   Superior Temporal Gyrus, anterior division   -5.41 64 -8 -2 
   Superior Temporal Gyrus, posterior division   -5.16 66 -30 4 
Cluster 5 (Sub-lobar) 19.1 < 0.0001     
   Cerebral White Matter   -6.51 -60 -30 10 
   Cingulate Gyrus, posterior division   -6.14 -50 -40 16 
   Thalamus   -5.28 -44 -20 10 
   Thalamus   -4.88 -56 -12 2 
   Cerebral White Matter   -4.76 -44 -24 16 
   Cerebral White Matter   -4.54 -64 -10 14 
Cluster 6 (Parietal Lobe) 5.44 < 0.0001     
   Supramarginal Gyrus, posterior division   -5.84 42 -46 40 
   Supramarginal Gyrus, posterior division,   -5.39 50 -50 42 
   Angular Gyrus   -5.14 38 -52 32 
   Lateral Occipital Cortex, superior division   -4.48 40 -64 34 
Cluster 7 (Limbic Lobe) 3.94 < 0.0001     
   Cingulate Gyrus, posterior division   -4.27 6 -30 38 
   Lateral Ventrical   -4.08 14 -38 16 
   Cerebral White Matter   -4.04 2 -22 20 
   Cerebral White Matter   -3.98 18 -42 12 
   Cingulate Gyrus, anterior division   -3.73 4 -14 28 
   Cingulate Gyrus, posterior division   -3.66 0 -28 30 
 
Coordinates (in MNI space) and Z score maxima for cluster-based statistical contrasts (all Z > 3.1, p < 
0.05). Only clusters larger than 2 ml are shown. Clusters are first named by their general position 
according to the Talairach Daemon, while maxima are named according to the structure with the 
highest probability at that position in the Harvard-Oxford Cortical and Subcortical Structural Atlases.  
SUPPLEMENTARY TABLE 6. 
 
Monetary incentive delay: task characterisation and between centre examination 
 London Cambridge Manchester ANOVA Combined  
 (n=15) (n=15) (n=13) (n=15,15,13) (n=43) 
Amount won (£) 9.73 ± 3.26 10.37 ± 3.18 8.12 ± 1.33 F2,40 = 2.38, p = 0.11 
# 9.47 ± 2.88 
Accuracy: reward (%) 66 ± 12 68 ± 11 62 ± 6 F2,40 = 1.45, p = 0.25 
# 66 ± 10 
Accuracy: neutral (%) 63 ± 11 67 ± 11 58 ± 7 F2,40 = 2.90, p = 0.07 
# 63 ± 11 
Accuracy: loss (%) 64 ± 20 70 ± 21 50 ± 8 Welch’s F2,23.3 = 8.00, p = 0.002 
‡ 62 ± 19 
Hit response time: 
reward (ms) 
211 ± 21 205 ± 25 224 ± 14 F2,40 = 2.97, p = 0.06 213 ± 22 
Hit Response time: 
neutral (ms) 
215 ± 22 209 ± 24 226 ± 9 F2,40 = 2.49, p = 0.10 216 ± 21 
Hit Response time: loss 
(ms) 
207 ± 19 198 ± 22 219 ± 8 F2,40 = 4.45, p = 0.018 
‡ 208 ± 19 
Striatal ROI: win 
anticipation > neutral 
anticipation (% signal) a 
0.28 ± 0.28 0.30 ± 0.27 0.28 ± 0.30 F2,40 = 0.02, p = 0.98 0.28 ± 0.27 
Striatal ROI: win 
anticipation > neutral 
anticipation (Z score) a 
1.91 ± 2.05 2.35 ± 2.13 1.97 ± 2.04 F2,40 = 0.19, p = 0.83 2.08 ± 2.04 
Motion (mm/s) 0.12 ± 0.21 0.07 ± 0.01 0.07 ± 0.02 F2,40 = 0.90, p = 0.41 
† 0.09 ± 0.13 
 
†Normality assumptions of at least one subgroup violated (Shapiro-Wilk test), but no significant differences between groups 
found using a non-parametric test (Kruskal-Wallis). 
‡Normality assumptions of at least one subgroup violated (Shapiro-Wilk test), significant differences between groups also found 
using a non-parametric test (Kruskal-Wallis). 
#Normality assumptions of at least one subgroup violated (Shapiro-Wilk test), significant differences between groups also found 
using a non-parametric test (Kruskal-Wallis), but are not significant after a Bonferroni correction for number of independent tests 
performed on this task (~ 7). 
aThese values represent the means of the raw numbers extracted on an individual basis. Higher values are reported in the main 
text after the full mixed effects model has been carried out, and accounting for centre, age, and sex. 
  
SUPPLEMENTARY TABLE 7. 
 
Go/no-go: task characterisation and between centre examination 
 London Cambridge Manchester ANOVA Combined  
 (n=15) (n=15) (n=13) (n=15,15,13) (n=43) 
Accuracy: go (%) 96 ± 6 94 ± 19 97 ± 5 F2,40 = 0.53, p = 0.77 
† 96 ± 12 
Accuracy: no-go (%) 65 ± 17 66 ± 16 71 ± 15 F2,40 = 0.47, p = 0.63 67 ± 16 
Go response time (ms) 339 ± 75 313 ± 65 326 ± 57 F2,40 = 0.55, p = 0.58 326 ± 66 
No-go response time 
(ms) 
295  ± 79 278 ± 85 274 ± 48 F2,40 = 0.33, p = 0.72 
† 283 ± 72 
Striatal ROI: no-go > go 
(a.u.) a 
0.22 ± 0.12 0.17 ± 0.14 0.26 ± 0.16 F2,40 = 1.33, p = 0.28 0.21 ± 0.14 
Striatal ROI: no-go > go  
(Z score) a 
1.46 ± 0.79 1.30 ± 0.99 1.41 ± 0.74 F2,40 = 0.15, p = 0.87 1.39 ± 0.83 
Motion (mm/s) 0.06 ± 0.03 0.06 ± 0.02 0.05 ± 0.02 F2,40 = 1.05, p = 0.36 
† 0.06 ± 0.02 
 
†Normality assumptions of at least one subgroup violated (Shapiro-Wilk test), but no significant differences between groups 
found using a non-parametric test (Kruskal-Wallis). 
aThese values represent the means of the raw numbers extracted on an individual basis. Higher values are reported in the main 
text after the full mixed effects model has been carried out, and accounting for centre, age, and sex. 
 
“No-go response time” is that of unsuccessful no-go. a.u. = arbitrary units.  
SUPPLEMENTARY TABLE 8. 
 
Evocative images: task characterisation and between centre examination 
 London Cambridge Manchester ANOVA Combined  
 (n=15) (n=15) (n=13) (n=15,15,13) (n=43) 
Neutral response time (ms) 750 ± 242 587 ± 172 680 ± 276 F2,40 = 1.88, p = 0.17 
† 672 ± 236 
Aversive response time (ms) 778 ± 255 596 ± 157 696 ± 289 F2,40 = 2.20, p = 0.12 
† 689 ± 244 
Difference in response time 
(aversive -neutral) (ms) 
24 ± 119 9 ± 67 15 ± 82 Welch’s F2,25.2 = 0.14, p = 0.87 17 ± 90 
Amygdala ROI: aversive > 
neutral (% signal) a 
0.31 ± 0.23 0.29 ± 0.26 0.02 ± 0.32 F2,40 = 5.06, p = 0.01 
‡ 0.21 ± 0.29 
Amygdala ROI: aversive > 
neutral  (Z score) a 
1.54 ± 1.09 1.51 ± 1.13 0.26 ± 1.08 F2,40 = 5.98, p = 0.005 1.15 ± 1.23 
Motion (mm/s) 0.09 ± 0.03 0.07 ± 0.03 0.08 ± 0.05 F2,40 = 0.69, p = 0.51 
† 0.08 ± 0.04 
 
†Normality assumptions of at least one subgroup violated (Shapiro-Wilk test), but no significant differences between groups found 
using a non-parametric test (Kruskal-Wallis). 
‡Normality assumptions of at least one subgroup violated (Shapiro-Wilk test), significant differences between groups also found 
using a non-parametric test (Kruskal-Wallis). 
aThese values represent the means of the raw numbers extracted on an individual basis. Higher values are reported in the main text 
after the full mixed effects model has been carried out, and accounting for centre, age, and sex. 
 
